StockData
Avalo Therapeutics, Inc. logo

Avalo Therapeutics, Inc. (AVTX) stock

AVTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$7.13−0.24 (-3.26%)

Close on Nov 17, 2026Market cap $382.38MP/E –Yield –

Avalo Therapeutics EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Avalo Therapeutics's EV/EBITDA was 14.1× on Oct 31, 2018.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2018Oct 31, 201814.1×+10.5
2017Dec 29, 20173.6×–

More Avalo Therapeutics figures

See a number that looks wrong?